Publikationen, an denen er mitarbeitet Laura Ochoa Callejero (22)

2022

  1. CCL5 Levels Predict Stroke Volume Growth in Acute Ischemic Stroke and Significantly Diminish in Hemorrhagic Stroke Patients

    International journal of molecular sciences, Vol. 23, Núm. 17

2021

  1. Adrenomedullin as a potential biomarker involved in patients with hereditary hemorrhagic telangiectasia

    European Journal of Internal Medicine, Vol. 88, pp. 89-95

  2. Adrenomedullin is a diagnostic and prognostic biomarker for acute intracerebral hemorrhage

    Current Issues in Molecular Biology, Vol. 43, Núm. 1, pp. 324-334

  3. Maraviroc prevents hcc development by suppressing macrophages and the liver progenitor cell response in a murine chronic liver disease model

    Cancers, Vol. 13, Núm. 19

  4. Response to Letter to the Editor from Abobaker and Darrat: "circulating levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients"

    Journal of the Endocrine Society

2020

  1. Author Correction: Lack of adrenomedullin in mouse endothelial cells results in defective angiogenesis, enhanced vascular permeability, less metastasis, and less brain damage (Scientific Reports, (2016), 6, 1, (33495), 10.1038/srep33495)

    Scientific Reports

  2. Macrocybin, a Natural Mushroom Triglyceride, Reduces Tumor Growth In Vitro and In Vivo through Caveolin-Mediated Interference with the Actin Cytoskeleton

    Molecules (Basel, Switzerland), Vol. 25, Núm. 24

2017

  1. Small molecules related to adrenomedullin reduce tumor burden in a mouse model of colitis-associated colon cancer

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Lack of adrenomedullin in mouse endothelial cells results in defective angiogenesis, enhanced vascular permeability, less metastasis, and more brain damage

    Scientific Reports, Vol. 6

  2. Prevention of bone loss in a model of postmenopausal osteoporosis through adrenomedullin inhibition

    Frontiers in Physiology, Vol. 7

  3. Temporal profiles of blood pressure, circulating nitric oxide, and adrenomedullin as predictors of clinical outcome in acute ischemic stroke patients

    Molecular Medicine Reports, Vol. 13, Núm. 5, pp. 3724-3734

2014

  1. Adrenomedullin and tumour microenvironment

    Journal of Translational Medicine, Vol. 12, Núm. 1

2013

  1. Adrenomedullin Peptides

    Handbook of Biologically Active Peptides (Elsevier Inc.), pp. 990-995

  2. Expression of matrix metalloproteinases and their inhibitors in the woodchuck model of hepatocellular carcinoma

    Journal of Medical Virology, Vol. 85, Núm. 7, pp. 1127-1138

  3. Is the cytoskeleton an intracellular receptor for adrenomedullin and PAMP?

    Current Protein and Peptide Science, Vol. 14, Núm. 5, pp. 429-433

  4. Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model

    PLoS ONE, Vol. 8, Núm. 1

  5. Vascular endothelial adrenomedullin-RAMP2 system is essential for vascular integrity and organ homeostasis

    Circulation, Vol. 127, Núm. 7, pp. 842-853

2012

  1. Adrenomedullin as a growth and cell fate regulatory factor for adult neural stem cells

    Stem Cells International

  2. Identification of first proadrenomedullin N-terminal 20 peptide (PAMP) modulator by means of virtual screening and NMR interaction experiments

    European Journal of Medicinal Chemistry, Vol. 55, pp. 262-272

  3. Role of Adrenomedullin in the Growth and Differentiation of Stem and Progenitor Cells

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 175-234